Biotech By Jonathan Wosen Guardant accuses Illumina of ‘brazen’ attempt to quash competition in ongoing legal battle
The Readout LOUD By Adam Feuerstein and Meg Tirrell Listen: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges
Pharmalot By Ed Silverman As monkeypox spreads, Bavarian Nordic’s CEO is fielding calls for his vaccine, but doesn’t see panic
D.C. Diagnosis By Rachel Cohrs California senators advance three bills meant to crack down on health insurers
Biotech By Ryan Cross — The Boston Globe Flagship’s latest startup launches with bold claim: the discovery of thousands of new human proteins
Pharmalot By Ed Silverman Pharmalittle: Teva and Allergan reach $161 million opioid settlement with West Virginia; FDA lifts hold on Bharat Covid shot
Politics By Rachel Cohrs Key Senate panel wants to axe in-person requirement for virtual mental health services
Opinions+ By Emily Johnson and Jenna Phillips QR codes can help pharmaceutical companies in two big ways
Health By Damian Garde Raising ‘good’ cholesterol doesn’t protect against heart disease after all, study finds
Biotech By Damian Garde These pricey cholesterol drugs aren’t selling. And that has the biotech industry sweating
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Another analysis finds new cholesterol drugs are not cost-effective
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Are too many companies chasing the same kind of cancer drug?
Pharmalot By Ed Silverman Aegerion to pay $40M and plead guilty to illegally marketing cholesterol drug
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Cigna to get discounts if cholesterol meds don’t work
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Little company makes big bet on discarded Roche drug
Pharmalot By Ed Silverman Docs won’t prescribe pricey new cholesterol meds unless they lower heart risks
Health By Associated Press Cholesterol-lowering statins cut heart disease risk in people with slightly high blood pressure
Pharmalot By Ed Silverman Why one analyst thinks a Sanofi and Regeneron cholesterol drug will be yanked
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: setback for Merck, Valeant to offer discounts at Walgreens
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: US drug prices are highest, UnitedHealth favors Regeneron
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: CVS covers new cholesterol drug, FDA Duchenne hearing